Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01312428 · ClinicalTrials.gov registry record · NA

Pelvic Alignment Level (PAL) Instrument Evaluation

A NA study, sponsored by Stryker Orthopaedics.

Terminated
Registry status
NA
Development phase
7
Enrollment target

NCT01312428 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01312428, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.

TERMINATED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

The study is conducted to evaluate the performance of the Pelvic Alignment Level (PAL) instrument in achieving desired acetabular position, desired leg length and offset after Total Hip Replacement (THR) reconstruction.

Interventions

  • DEVICE Pelvic Alignment Level (PAL) Instrument
  • DEVICE No Pelvic Alignment Level (PAL) Instrument

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2011-02
Est. Completion 2012-04
Phase NA

Sponsor

Stryker Orthopaedics

27 total trials

What the Registry Record Tells You About NCT01312428

The ClinicalTrials.gov registry entry for NCT01312428 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Pelvic Alignment Level (PAL) Instrument is the first listed.

NCT01312428 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01312428 about?

NCT01312428 is a clinical study titled "Pelvic Alignment Level (PAL) Instrument Evaluation". The study is conducted to evaluate the performance of the Pelvic Alignment Level (PAL) instrument in achieving desired acetabular position, desired leg length and offset after Total Hip Replacement (THR) reconstruction.

What is the current status of trial NCT01312428?

This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2011-02. Estimated completion is 2012-04.

What interventions are being tested in trial NCT01312428?

The interventions under investigation include: Pelvic Alignment Level (PAL) Instrument (DEVICE), No Pelvic Alignment Level (PAL) Instrument (DEVICE).

Who is sponsoring clinical trial NCT01312428?

This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.